Evaluation of social effects from the implementation of various innovative methods of diagnostics and treatment in the profiles of «cardiovascular surgery» and «neurosurgery» in a multidisciplinary medical organization at the regional level

Abstract


Aim. To evaluate the social effects of the implementation of various innovative diagnostic and treatment methods in the fields of cardiovascular surgery and neurosurgery in a regional multidisciplinary medical organization. Methods. This study is based on an organizational experiment, the purpose of which was to test and evaluate the effectiveness of a proprietary set of organizational and management technologies designed to optimize the implementation of innovative diagnostic and treatment methods in a multidisciplinary hospital. The main group (n=125) included patients who received medical care using the innovative diagnostic and treatment methods introduced as part of the experiment. The comparison group (n=68) included patients who received treatment using standard («routine») diagnostic and treatment methods for similar nosologies, comparable in clinical complexity and patient age. The total sample for the sociological study consisted of 193 people. Results. Patients' opinions on the quality of care provided varied significantly depending on the innovative method used (p=0.0031, Kruskal-Wallis test). The highest average scores were assigned to minimally invasive endovascular interventions: endovascular embolization of vessels and balloon angioplasty (5.00 points each on a 5-point scale). Cryoballoon ablation of the pulmonary vein orifices demonstrated a comparably high result (4.91 points). The integrated indicator of overall satisfaction, assessed on a 10-point scale (Figure 3), demonstrated the most pronounced and highly reliable differences between the groups (p=0.00001, Kruskal-Wallis test). The undisputed leaders were endovascular embolization of vessels (10.00 points) and balloon angioplasty (9.94 points). Patients who underwent endovascular laser coagulation (9.11 points) and radiofrequency thermal ablation (8.78 points) also expressed high satisfaction. Cryoballoon ablation, which demonstrated the best results in terms of quality of life, achieved a more moderate, but still high, score (7.30) in this parameter. Conclusion. Planning for the implementation of innovative technologies should consider not only clinical and economic benefits but also the predicted socio-psychological effectiveness, which varies significantly between different methods. For technologies with delayed clinical and functional results (for example, in spinal surgery), it is necessary to develop and integrate structured patient information programs and support during the rehabilitation period into the treatment process to enhance the positive social impact.

About the authors

Artur Rudolfovich Gabrielyan

State Budgetary Institution of Healthcare of the City of Moscow «City Clinical Hospital named after A. K. Yeramishantsev of the Moscow City Health Department», Moscow, Russian Federation; N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russian Federation

Email: gabrielyanarthur@gmail.com

References

  1. Rahman M. H. et al. Social franchising in healthcare: a systematic review and narrative synthesis of implementation and outcomes. BMJ Global Health. 2025;10(2). doi: 10.1136/bmjgh-2024-017101
  2. Bunn F., Goodman C., Corazzini K., Sharpe R., Handley M., Lynch J., et al. Setting Priorities to Inform Assessment of Care Homes' Readiness to Participate in Healthcare Innovation: A Systematic Mapping Review and Consensus Process. Int. J. Environ. Res. Public Health. 2020;17. doi: 10.3390/ijerph17030987
  3. Greenwood K., Robertson S., Vogel E., Vella C., Ward T., McGourty A., et al. The impact of Patient and Public Involvement in the SlowMo study: Reflections on peer innovation. Heal. Expect. an Int. J. public Particip. Heal. care Heal. policy. 2022;25:191—202. doi: 10.1111/hex.13362
  4. Chang L. S., Vaduganathan M., Plutzky J., Aroda V. R. Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration. Curr. Diab. Rep. 2019;19:157. doi: 10.1007/s11892-019-1260-0
  5. Abrams H. R., Durbin S., Huang C. X., Johnson S. F., Nayak R. K., Zahner G. J., et al. Financial toxicity in cancer care: origins, impact, and solutions. Transl. Behav. Med. 2021;11:2043—54. doi: 10.1093/tbm/ibab091
  6. Fahey E., Elsheikh M. F.H., Davey M. S., Rowan F., Cassidy J. T., Cleary M. S. Telemedicine in Orthopedic Surgery: A Systematic Review of Current Evidence. Telemed. J. e-health Off. J. Am. Telemed. Assoc. 2022;28:613—35. doi: 10.1089/tmj.2021.0221
  7. Agarwal S., Perry H. B., Long L. A., Labrique A. B. Evidence on feasibility and effective use of mHealth strategies by frontline health workers in developing countries: systematic review. Trop. Med. Int. Health. 2015;20:1003—14. doi: 10.1111/tmi.12525
  8. Grustam A. S., Severens J. L., De Massari D., Buyukkaramikli N., Koymans R., Vrijhoef H. J. M. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management. Value Heal. J. Int. Soc. Pharmacoeconomics Outcomes Res. 2018;21:772—82. doi: 10.1016/j.jval.2017.11.011
  9. Nasir K., Javed Z., Khan S. U., Jones S. L., Andrieni J. Big Data and Digital Solutions: Laying the Foundation for Cardiovascular Population Management (CME). Methodist Debakey Cardiovasc. J. 2020;16:272—82. doi: 10.14797/mdcj-16-4-272
  10. Tierney W. M., Rousseau J. F., Khurshid A. Measuring and Managing Population Health. Tex. Med. 2018;114:42—51.
  11. Albaghdadi A. T., Al Daajani M. M. Perceptions, Satisfaction, and Barriers to Telemedicine Use: A Community-Based Study From Jeddah, Saudi Arabia. Cureus. 2023;15:e40738. doi: 10.7759/cureus.40738

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 1970 ФГБНУ Национальный НИИ Общественного здоровья имени Н.А. Семашко

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: r.bulletin@yandex.ru

Phone: +7 (495) 917-90-41 add. 136



Principal Contact

Kuzmina Uliia Aleksandrovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: r.bulletin@yandex.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies